发明名称 COMPOSITION AND METHOD FOR PREVENTING RESTENOSIS FOLLOWING REVASCULARIZATION PROCEDURE
摘要 PROBLEM TO BE SOLVED: To provide a method which reduces or prevents restenosis following invasiveness revascularization procedures, and to provide a composition therefor. SOLUTION: The method for reducing or preventing the restenosis that occurs following the revascularization procedure, comprises administering to a mammal in need of such treatment a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and an active agent selected from a group consisting of, (a) a selective adenosine A<SB>2A</SB>receptor agonist, (b) the combination of a selective adenosine A<SB>1</SB>antagonist and either a selective adenosine A<SB>2A</SB>receptor agonist or a non-selective adenosine agonist, and (c) a selective adenosine A<SB>1</SB>antagonist in order to block the adenosine A<SB>1</SB>receptor activation by endogenously released adenosine. An surgical procedure is also improved relies on selective stimulation of adenosine A<SB>2A</SB>receptors. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009149668(A) 申请公布日期 2009.07.09
申请号 JP20090034613 申请日期 2009.02.17
申请人 ADERIS PHARMACEUTICALS INC 发明人 MARTIN PAULINE L;MCAFEE DONALD A
分类号 A61K45/00;A61K31/00;A61K31/437;A61K31/4545;A61K31/52;A61K31/522;A61K31/525;A61K31/70;A61K31/7076;A61K45/06;A61P9/00;A61P9/10;A61P41/00;A61P43/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址